Rite Aid is implementing a number of strategies to make up Q3 2021 PBM revenue shortfall, including closing 63 stores and improving PBM margins from its new rebate aggregation agreement with Prime Therapeutics
Aetna recently announced an initiative to launch a designated network to cover new gene therapies for rare diseases. This follows an initiative by CVS Health in 2019 to provide self-insured employers with a stop-loss program with Aetna health plans and cover gene therapies
AllianceRx Walgreens Prime (AllianceRx) is offering Arcalyst (rilonacept) and Gavreto (pralsetinib), two medicines prescribed for the treatment of specific kinds of cancer as well as an autoinflammatory cardiovascular disease
AllianceRx Walgreens Prime’s digital clinical assessments are available for patients with chronic inflammatory disease, multiple sclerosis, cystic fibrosis, idiopathic pulmonary fibrosis, organ transplants, lipid and blood disorders
The largest specialty pharmacies are owned by organizations that are increasingly integrating their product and service offerings such as CVS Health, Cigna’s Express Scripts, UnitedHealth Group’s OptumRx, and Walgreens Boots Alliance/Prime Therapeutics
AllianceRx is continuing to taking steps to help patients with chronic or complex conditions better manage their care online
A new patented process for delivering specialty medicine will assure AllianceRx Walgreens Prime patients receive their medicine delivered at the correct temperature
Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers